In Reply

Affiliations

Comment

Bassam Haddad. Obstet Gynecol. 2017 Feb.

. 2017 Feb;129(2):388.

doi: 10.1097/AOG.0000000000001883.

No abstract available

Comment on

Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, Tsatsaris V, Benachi A, Bretelle F, Gris JC, Bastuji-Garin S; Heparin-Preeclampsia (HEPEPE) Trial Investigators. Haddad B, et al. Obstet Gynecol. 2016 Nov;128(5):1053-1063. doi: 10.1097/AOG.0000000000001673. Obstet Gynecol. 2016. PMID: 27741174 Clinical Trial.
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Demers S, Bujold E, Roberge S. Demers S, et al. Obstet Gynecol. 2017 Feb;129(2):387-388. doi: 10.1097/AOG.0000000000001882. Obstet Gynecol. 2017. PMID: 28121820 No abstract available.

1. Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, et al. Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial. Obstet Gynecol 2016;128:1053–63.
1. Roberge S, Demers S, Nicolaides KH, Bureau M, Cote S, Bujold E. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a metaanalysis. Ultrasound Obstet Gynecol 2016;47:548–53.
1. Rodger MA, Gris JC, de Vries JI, Martinelli I, Rey É, Schleussner E, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Lancet 2016;388:2629–41.